These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Multiple testing to establish superiority/equivalence of a new treatment compared with k standard treatments for unbalanced designs. Kwong KS; Cheung SH; Chan WS Biometrics; 2004 Jun; 60(2):491-8. PubMed ID: 15180675 [TBL] [Abstract][Full Text] [Related]
6. Finding the maximum safe dose level for heteroscedastic data. Tamhane AC; Logan BR J Biopharm Stat; 2004 Nov; 14(4):843-56. PubMed ID: 15587967 [TBL] [Abstract][Full Text] [Related]
7. A note on Shirley's nonparametric test for comparing several dose levels with a zero-dose control. Williams DA Biometrics; 1986 Mar; 42(1):183-6. PubMed ID: 3719054 [TBL] [Abstract][Full Text] [Related]
8. Some results on step-up tests for comparing treatments with a control in unbalanced one-way layouts. Liu W Biometrics; 1997 Dec; 53(4):1508-12. PubMed ID: 9423265 [TBL] [Abstract][Full Text] [Related]
9. Dunnett's many-to-one test and least square means. Shun Z; Silverberg A; Chang CK; Ouyang P J Biopharm Stat; 2003 Feb; 13(1):17-28. PubMed ID: 12635900 [TBL] [Abstract][Full Text] [Related]
10. Two-stage designs for dose-finding trials with a biologic endpoint using stepwise tests. Polley MY; Cheung YK Biometrics; 2008 Mar; 64(1):232-41. PubMed ID: 17573866 [TBL] [Abstract][Full Text] [Related]
11. Prediction approaches to sequentially searching for an optimal dose. Shih WJ Biometrics; 1989 Jun; 45(2):623-8. PubMed ID: 2669990 [TBL] [Abstract][Full Text] [Related]
12. Approximate simultaneous confidence intervals for multiple contrasts of binomial proportions. Schaarschmidt F; Sill M; Hothorn LA Biom J; 2008 Oct; 50(5):782-92. PubMed ID: 18932137 [TBL] [Abstract][Full Text] [Related]
13. Step-down trend tests for identifying the minimum effective dose. Amaratunga D; Ge N J Biopharm Stat; 1998 Mar; 8(1):151-62. PubMed ID: 9547433 [TBL] [Abstract][Full Text] [Related]
14. Testing for trends in dose-response microarray experiments: a comparison of several testing procedures, multiplicity and resampling-based inference. Lin D; Shkedy Z; Yekutieli D; Burzykowski T; Göhlmann HW; De Bondt A; Perera T; Geerts T; Bijnens L Stat Appl Genet Mol Biol; 2007; 6():Article26. PubMed ID: 18052909 [TBL] [Abstract][Full Text] [Related]
15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
16. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
17. A step-up test procedure to find the minimum effective dose. Wang W; Peng J J Biopharm Stat; 2015; 25(3):525-38. PubMed ID: 24905396 [TBL] [Abstract][Full Text] [Related]
18. Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni-based closed tests. Strassburger K; Bretz F Stat Med; 2008 Oct; 27(24):4914-27. PubMed ID: 18618415 [TBL] [Abstract][Full Text] [Related]
19. Closure procedures for monotone bi-factorial dose-response designs. Hellmich M; Lehmacher W Biometrics; 2005 Mar; 61(1):269-76. PubMed ID: 15737103 [TBL] [Abstract][Full Text] [Related]
20. Global tests for multiple binary outcomes. Lefkopoulou M; Ryan L Biometrics; 1993 Dec; 49(4):975-88. PubMed ID: 8117908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]